Loading…
Hindered nucleoside analogs as antiflaviviridae agents
Flaviviridae are an important family of viruses, responsible for widely spread diseases such as dengue and West Nile fever and hepatitis C. Despite the severity of the related diseases, no effective antiviral treatments for infection are available. Following our discovery of adenosine-hindered analo...
Saved in:
Published in: | Pure and applied chemistry 2004-01, Vol.76 (5), p.1007-1015 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c515t-2b03e8e6582474abf16330300e3f761c42fb09a6493a809d43e4ff4c3eb1b69d3 |
---|---|
cites | |
container_end_page | 1015 |
container_issue | 5 |
container_start_page | 1007 |
container_title | Pure and applied chemistry |
container_volume | 76 |
creator | Manfredini, Stefano Angusti, Angela Veronese, A. C. Durini, Elisa Vertuani, S. Nalin, F. Solaroli, N. Pricl, S. Ferrone, Marco Mura, M. Piano, M. A. Poddesu, B. Cadeddu, Alessandra Colla, P. La Loddo, Roberta |
description | Flaviviridae are an important family of viruses, responsible for widely spread diseases such as dengue and West Nile fever and hepatitis C. Despite the severity of the related diseases, no effective antiviral treatments for infection are available. Following our discovery of adenosine-hindered analogs as potent antiflaviviridae agents, we have continued our investigation on guanosine and inosine derivatives, which were evaluated for activity against BVDV, YFV, DENV, and WNV viruses in cell-based assays. The present study allowed us to identify some newer features that led to improve the antiviral potency (down to the µM range) and to selectively inhibit BVDV and YFV viruses. The molecular modeling results were consistent with the hypothesis that test analogs act as RNA-dependent RNA polymerase (RdRp) inhibitors by interacting with a surface allosteric binding pocket. |
doi_str_mv | 10.1351/pac200476051007 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_607045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2230063157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-2b03e8e6582474abf16330300e3f761c42fb09a6493a809d43e4ff4c3eb1b69d3</originalsourceid><addsrcrecordid>eNp1kc9LwzAUx4MoOKdnrwPPdS_Nr_YiyFAnDLzoOaTNy-is7Uzajf33ZnQ6EAaBPJLP5_tCHiG3FO4pE3S6NmUKwJUEQQHUGRlRJkXCQIlzMgJgLOGCi0tyFcIKIpnzdETkvGoserSTpi9rbENlcWIaU7fLMDFxNV3larOpNpWvrIl3S2y6cE0unKkD3hz2Mfl4fnqfzZPF28vr7HGRlIKKLkkLYJihFFnKFTeFo5IxYADInJK05KkrIDeS58xkkFvOkDvHS4YFLWRu2ZgkQ27Y4rov9NpXX8bvdGsqfTj6jBVqCQq4iLw6ya99a4_Sr0hzwTKponk3mBH77jF0etX2Pn5E0GkaXywZFXtqOlClb0Pw6P46UND7Meh_Y4jGw2BsTd2ht7j0_S4Wx_gTppJDwA-P-I7R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2230063157</pqid></control><display><type>article</type><title>Hindered nucleoside analogs as antiflaviviridae agents</title><source>Free Full-Text Journals in Chemistry</source><creator>Manfredini, Stefano ; Angusti, Angela ; Veronese, A. C. ; Durini, Elisa ; Vertuani, S. ; Nalin, F. ; Solaroli, N. ; Pricl, S. ; Ferrone, Marco ; Mura, M. ; Piano, M. A. ; Poddesu, B. ; Cadeddu, Alessandra ; Colla, P. La ; Loddo, Roberta</creator><creatorcontrib>Manfredini, Stefano ; Angusti, Angela ; Veronese, A. C. ; Durini, Elisa ; Vertuani, S. ; Nalin, F. ; Solaroli, N. ; Pricl, S. ; Ferrone, Marco ; Mura, M. ; Piano, M. A. ; Poddesu, B. ; Cadeddu, Alessandra ; Colla, P. La ; Loddo, Roberta</creatorcontrib><description>Flaviviridae are an important family of viruses, responsible for widely spread diseases such as dengue and West Nile fever and hepatitis C. Despite the severity of the related diseases, no effective antiviral treatments for infection are available. Following our discovery of adenosine-hindered analogs as potent antiflaviviridae agents, we have continued our investigation on guanosine and inosine derivatives, which were evaluated for activity against BVDV, YFV, DENV, and WNV viruses in cell-based assays. The present study allowed us to identify some newer features that led to improve the antiviral potency (down to the µM range) and to selectively inhibit BVDV and YFV viruses. The molecular modeling results were consistent with the hypothesis that test analogs act as RNA-dependent RNA polymerase (RdRp) inhibitors by interacting with a surface allosteric binding pocket.</description><identifier>ISSN: 0033-4545</identifier><identifier>EISSN: 1365-3075</identifier><identifier>DOI: 10.1351/pac200476051007</identifier><language>eng</language><publisher>Berlin: De Gruyter</publisher><subject>Analogs ; Hepatitis C ; Medicin och hälsovetenskap ; RNA polymerase ; Viral diseases ; Viruses</subject><ispartof>Pure and applied chemistry, 2004-01, Vol.76 (5), p.1007-1015</ispartof><rights>2013 Walter de Gruyter GmbH, Berlin/Boston</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515t-2b03e8e6582474abf16330300e3f761c42fb09a6493a809d43e4ff4c3eb1b69d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,314,780,784,789,790,885,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1953867$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Manfredini, Stefano</creatorcontrib><creatorcontrib>Angusti, Angela</creatorcontrib><creatorcontrib>Veronese, A. C.</creatorcontrib><creatorcontrib>Durini, Elisa</creatorcontrib><creatorcontrib>Vertuani, S.</creatorcontrib><creatorcontrib>Nalin, F.</creatorcontrib><creatorcontrib>Solaroli, N.</creatorcontrib><creatorcontrib>Pricl, S.</creatorcontrib><creatorcontrib>Ferrone, Marco</creatorcontrib><creatorcontrib>Mura, M.</creatorcontrib><creatorcontrib>Piano, M. A.</creatorcontrib><creatorcontrib>Poddesu, B.</creatorcontrib><creatorcontrib>Cadeddu, Alessandra</creatorcontrib><creatorcontrib>Colla, P. La</creatorcontrib><creatorcontrib>Loddo, Roberta</creatorcontrib><title>Hindered nucleoside analogs as antiflaviviridae agents</title><title>Pure and applied chemistry</title><description>Flaviviridae are an important family of viruses, responsible for widely spread diseases such as dengue and West Nile fever and hepatitis C. Despite the severity of the related diseases, no effective antiviral treatments for infection are available. Following our discovery of adenosine-hindered analogs as potent antiflaviviridae agents, we have continued our investigation on guanosine and inosine derivatives, which were evaluated for activity against BVDV, YFV, DENV, and WNV viruses in cell-based assays. The present study allowed us to identify some newer features that led to improve the antiviral potency (down to the µM range) and to selectively inhibit BVDV and YFV viruses. The molecular modeling results were consistent with the hypothesis that test analogs act as RNA-dependent RNA polymerase (RdRp) inhibitors by interacting with a surface allosteric binding pocket.</description><subject>Analogs</subject><subject>Hepatitis C</subject><subject>Medicin och hälsovetenskap</subject><subject>RNA polymerase</subject><subject>Viral diseases</subject><subject>Viruses</subject><issn>0033-4545</issn><issn>1365-3075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp1kc9LwzAUx4MoOKdnrwPPdS_Nr_YiyFAnDLzoOaTNy-is7Uzajf33ZnQ6EAaBPJLP5_tCHiG3FO4pE3S6NmUKwJUEQQHUGRlRJkXCQIlzMgJgLOGCi0tyFcIKIpnzdETkvGoserSTpi9rbENlcWIaU7fLMDFxNV3larOpNpWvrIl3S2y6cE0unKkD3hz2Mfl4fnqfzZPF28vr7HGRlIKKLkkLYJihFFnKFTeFo5IxYADInJK05KkrIDeS58xkkFvOkDvHS4YFLWRu2ZgkQ27Y4rov9NpXX8bvdGsqfTj6jBVqCQq4iLw6ya99a4_Sr0hzwTKponk3mBH77jF0etX2Pn5E0GkaXywZFXtqOlClb0Pw6P46UND7Meh_Y4jGw2BsTd2ht7j0_S4Wx_gTppJDwA-P-I7R</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Manfredini, Stefano</creator><creator>Angusti, Angela</creator><creator>Veronese, A. C.</creator><creator>Durini, Elisa</creator><creator>Vertuani, S.</creator><creator>Nalin, F.</creator><creator>Solaroli, N.</creator><creator>Pricl, S.</creator><creator>Ferrone, Marco</creator><creator>Mura, M.</creator><creator>Piano, M. A.</creator><creator>Poddesu, B.</creator><creator>Cadeddu, Alessandra</creator><creator>Colla, P. La</creator><creator>Loddo, Roberta</creator><general>De Gruyter</general><general>Walter de Gruyter GmbH</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><scope>BNKNJ</scope><scope>BVBDO</scope></search><sort><creationdate>20040101</creationdate><title>Hindered nucleoside analogs as antiflaviviridae agents</title><author>Manfredini, Stefano ; Angusti, Angela ; Veronese, A. C. ; Durini, Elisa ; Vertuani, S. ; Nalin, F. ; Solaroli, N. ; Pricl, S. ; Ferrone, Marco ; Mura, M. ; Piano, M. A. ; Poddesu, B. ; Cadeddu, Alessandra ; Colla, P. La ; Loddo, Roberta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-2b03e8e6582474abf16330300e3f761c42fb09a6493a809d43e4ff4c3eb1b69d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Analogs</topic><topic>Hepatitis C</topic><topic>Medicin och hälsovetenskap</topic><topic>RNA polymerase</topic><topic>Viral diseases</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manfredini, Stefano</creatorcontrib><creatorcontrib>Angusti, Angela</creatorcontrib><creatorcontrib>Veronese, A. C.</creatorcontrib><creatorcontrib>Durini, Elisa</creatorcontrib><creatorcontrib>Vertuani, S.</creatorcontrib><creatorcontrib>Nalin, F.</creatorcontrib><creatorcontrib>Solaroli, N.</creatorcontrib><creatorcontrib>Pricl, S.</creatorcontrib><creatorcontrib>Ferrone, Marco</creatorcontrib><creatorcontrib>Mura, M.</creatorcontrib><creatorcontrib>Piano, M. A.</creatorcontrib><creatorcontrib>Poddesu, B.</creatorcontrib><creatorcontrib>Cadeddu, Alessandra</creatorcontrib><creatorcontrib>Colla, P. La</creatorcontrib><creatorcontrib>Loddo, Roberta</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><collection>SwePub Conference</collection><collection>SwePub Conference full text</collection><jtitle>Pure and applied chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manfredini, Stefano</au><au>Angusti, Angela</au><au>Veronese, A. C.</au><au>Durini, Elisa</au><au>Vertuani, S.</au><au>Nalin, F.</au><au>Solaroli, N.</au><au>Pricl, S.</au><au>Ferrone, Marco</au><au>Mura, M.</au><au>Piano, M. A.</au><au>Poddesu, B.</au><au>Cadeddu, Alessandra</au><au>Colla, P. La</au><au>Loddo, Roberta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hindered nucleoside analogs as antiflaviviridae agents</atitle><jtitle>Pure and applied chemistry</jtitle><date>2004-01-01</date><risdate>2004</risdate><volume>76</volume><issue>5</issue><spage>1007</spage><epage>1015</epage><pages>1007-1015</pages><issn>0033-4545</issn><eissn>1365-3075</eissn><abstract>Flaviviridae are an important family of viruses, responsible for widely spread diseases such as dengue and West Nile fever and hepatitis C. Despite the severity of the related diseases, no effective antiviral treatments for infection are available. Following our discovery of adenosine-hindered analogs as potent antiflaviviridae agents, we have continued our investigation on guanosine and inosine derivatives, which were evaluated for activity against BVDV, YFV, DENV, and WNV viruses in cell-based assays. The present study allowed us to identify some newer features that led to improve the antiviral potency (down to the µM range) and to selectively inhibit BVDV and YFV viruses. The molecular modeling results were consistent with the hypothesis that test analogs act as RNA-dependent RNA polymerase (RdRp) inhibitors by interacting with a surface allosteric binding pocket.</abstract><cop>Berlin</cop><pub>De Gruyter</pub><doi>10.1351/pac200476051007</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-4545 |
ispartof | Pure and applied chemistry, 2004-01, Vol.76 (5), p.1007-1015 |
issn | 0033-4545 1365-3075 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_607045 |
source | Free Full-Text Journals in Chemistry |
subjects | Analogs Hepatitis C Medicin och hälsovetenskap RNA polymerase Viral diseases Viruses |
title | Hindered nucleoside analogs as antiflaviviridae agents |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T23%3A05%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hindered%20nucleoside%20analogs%20as%20antiflaviviridae%20agents&rft.jtitle=Pure%20and%20applied%20chemistry&rft.au=Manfredini,%20Stefano&rft.date=2004-01-01&rft.volume=76&rft.issue=5&rft.spage=1007&rft.epage=1015&rft.pages=1007-1015&rft.issn=0033-4545&rft.eissn=1365-3075&rft_id=info:doi/10.1351/pac200476051007&rft_dat=%3Cproquest_swepu%3E2230063157%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c515t-2b03e8e6582474abf16330300e3f761c42fb09a6493a809d43e4ff4c3eb1b69d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2230063157&rft_id=info:pmid/&rfr_iscdi=true |